Skip to main content
Signal8
Elmaliah Oren profile photo

Oren Elmaliah

CIK: 0001713701

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)1 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Nasus Pharma Ltd logo
NSRX

Nasus Pharma Ltd

Officer
My Size, Inc. logo
MYSZ

My Size, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • My Size, Inc. logo
    MYSZ

    My Size, Inc.

    Dec 15, 2025
    Award(A)
    Direct
    30K shares-
  • My Size, Inc. logo
    MYSZ

    My Size, Inc.

    Jun 4, 2025
    Disposition(D)

    Option to purchase Common Stock (right to buy)

    Direct
    150 shares-
  • My Size, Inc. logo
    MYSZ

    My Size, Inc.

    Jun 4, 2025
    Award(A)

    Option to purchase Common Stock (right to buy)

    Direct
    150 shares-

1-3 of 3

About Elmaliah Oren

Elmaliah Oren (SEC CIK 0001713701) files insider reports with the SEC as Interim CFO of Nasus Pharma Ltd (NSRX) and Chief Financial Officer of My Size, Inc. (MYSZ).

Signal8 holds 3 ownership filings by Elmaliah Oren (1 Form 3, 2 Form 4), filed between Jun 6, 2025 and Sep 23, 2026. Those filings report 3 transactions, from Jun 4, 2025 to Dec 15, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Elmaliah Oren's filings is in TEL-AVIV-YAFO.

Recent filings by Elmaliah Oren

  • Dec 15, 2025: Grant or award of MYSZ shares (Form 4, code A).
  • Jun 4, 2025: Disposition to issuer transaction of MYSZ derivative securities (Form 4, code D).
  • Jun 4, 2025: Grant or award of MYSZ derivative securities (Form 4, code A).

Other insiders filing for Nasus Pharma Ltd (NSRX)

How to read Form 4 transaction codes